Vytorin

From FeedX

Enter your search terms Web feedx.net Submit search form

• brooklyn_decker eddie_levert alphonso_jackson gerald_levert kathie_lee_gifford vytorin cody_gifford aloha_airlines cesar_chavez_day bling_yourself

[edit] nandigramunited: Vytorin Linked to Heart Attacks, Stroke and Liver ...

30 November 2008, by Palash Biswas Vytorin may have done more harm than good when it comes to heart and liver problems. The blockbuster cholesterol drug was marketed to reduce cholesterol by regulating production of cholesterol in the liver and by blocking absorption of ...

[edit] Автор: jtsfds416

27 November 2008, by mammamia; bupropion; zyban online; buy cheap propecia; xenical; buy crestor; stress relief cheap; buy clomid online; trazodone; buy lamictal online; hyaluronic acid; norvasc; saw palmetto online buy; buy risperdal; buy plan b; generic glucophage; cialis; levaquin canada; rogaine; acyclovir; echinacea purchase; synthroid purchase online; soma; stop smoking; purchase carisoprodol; purim online; levitra; order zetia; breast augmentation; vytorin; actos; buy generic cla online; provera

[edit] Did antidepressant trigger suicide? - The Spokesman Review

25 November 2008, by

[edit] Did Henry Waxman Give Pharma & The FDA A Gift?

24 November 2008, by The consensus last week was that the upcoming change at House Energy & Commerce Committee, where California Democrat Henry Waxman will replace Michigan Democrat John Dingell, is something of a wash for pharma and the FDA. That’s because both men were known to be tough on drugmakers and regulators alike, and have launched numerous investigations into pricing, marketing and safety issues. But it may not be that simple, at least in the short run. The changeover, which made for compelling intrigue

[edit] Listen To Schering-Plough’s Fred Hassan In Action

24 November 2008, by The drugmaker is hosting an R&D update today for securities analysts, fund managers and the media, starting at 8:30 am EST, at its Kenilworth, New Jersey, facilities. Much of the discussion, as you can imagine, will be devoted to pipeline issues, and as Deutsche Bank analyst Barbara Ryan observed in an investor note about the gathering, “expectations…appear to be fairly low.” Schering-Plough “will probably also use the opportunity to highlight the positive aspects of its current business model

[edit] Автор: jtsfds143

22 November 2008, by mammamia; zetia order; buy skelaxin usa; amitriptyline; prednisone; coq10; strattera generic; glucophage; alli uk; cheap zyban; purchase methotrexate online; folic acid; buy generic vytorin; augmentin generic; valtrex buy; buy actonel; lamisil; stress relief; online diovan; buy levaquin; generic risperdal; ginseng; buy cheap effexor online; buy cymbalta online; saw palmetto online; premarin; buy cheap generic carisoprodol; online paxil; buy buspar; citalopram; depakote buy online

[edit] Correction: Merck ratings (AP)

19 November 2008, by In a Nov. 17 story about Merck and Co., The Associated Press erroneously reported the results of a clinical trial involving Merck's cholesterol drug Vytorin. The trial showed that Vytorin was no better than a generic drug at preventing arterial plaque buildup.

[edit] Disaster! Americans stop taking Lipitor.

19 November 2008, by Colin Rose Well, I predicted many years ago that the exorbitant cost of drugs for lifestyle diseases would at s

[edit] Disaster! Americans stop taking Lipitor.

19 November 2008, by Disaster! Americans stop taking Lipitor. Posted by Colin Rose on November 19, 2008 Well, I predicted many years ago that the exorbitant cost of drugs for lifestyle diseases would at some point destroy the cherished American ideal of unlimited consumption. It has happened a lot sooner than even I thought. The same attitude that powered the myth of free money and endless consumption of houses and goods is responsible for the myth of harmless gluttony while taking pills for “cholesterol”, hypert

[edit] Doctors debate cancer risk of Vytorin, Zetia

18 November 2008, by Hundreds of heart experts attended a panel discussion at the annual meeting of the American Heart Association to debate the benefits and risks of the cholesterol drugs Vytorin and Zetia.

[edit] Fitch Revises Merck & Co.'s Ratings Outlook to Negative - MarketWatch

17 November 2008, by

[edit] Vytorin and Zetia may have hit bottom - FiercePharma

17 November 2008, by

[edit] Justice Investigates Marketing of Vytorin by Merck and Schering-Plough - InjuryBoard.com

16 November 2008, by

[edit] Disorders Associated With a Deficiency of Coenzyme Q10

15 November 2008, by Coenzyme Q10 often called COQ10, is natural substance found in the cells of your body and is involved in many different cell processes, but primarily involved in energy production. There has been a significant amount of research involving COQ10 and its impact on human health. Deficiencies of COQ10 can be far [...]

[edit] Sales of Vytorin & Zetia Are Bad, but Not Getting Worse | Article Blog

15 November 2008, by unknown Schering-Plough has kept a promise its CFO made in February of this year: To provide regular reports on how the company’s beleaguered cholesterol franchise is holding ...

[edit] The Vytorin Limbo: Have Scrips Hit Bottom? - Pharmalot

14 November 2008, by

[edit] The Vytorin Limbo: Have Scrips Hit Bottom?

14 November 2008, by After months of precipitous decline with nary a respite, the increasingly downward trend in Vytorin prescriptions has hit a pause. Of course, one month does not a trend make, but could this be the bottom? We confess that we do not know. In any event, the latest monthly data shows prescriptions were flat in October. The previous month, scrips fell 3.7 percent reflecting ongoing confusion over the results of the SEAS clinical trial, which unexpectedly yielded a mysterious number of cases of canc

[edit] Sales of Vytorin & Zetia Are Bad, but Not Getting Worse - Wall Street Journal Blogs

14 November 2008, by

[edit] Merck, Schering-Plough Avert Vytorin ‘Disaster’ at Heart Meeting - Wall Street Journal Blogs

13 November 2008, by

[edit] Health Blog : Merck, Schering-Plough Avert Vytorin 'Disaster' at ...

13 November 2008, by unknown An absence of bad news about the companies' jointly marketed cholesterol drugs at a big heart meeting was enough to count as good news.

[edit] Vytorin Study to Get FDA Review

13 November 2008, by lsheppler1 Vytorin lowers bad cholesterol but does not reduce plaque build up

[edit] UPDATE 1-Doctors debate Vytorin cancer risk at heart meeting - Reuters

12 November 2008, by

[edit] FDA Investigates Possible Vytorin-Cancer Link :: Illinois Injury ...

11 November 2008, by unknown U.S. drug regulators are investigating whether the cholesterol-lowering drug Vytorin might be linked to cancer. The U.S. Food and Drug Administration informed health care professionals that the agency was investigating a report of a ...

[edit] Question: I have had a high cholesterol level for several years..

8 November 2008, by Question: I have had a high cholesterol level for several years. As a 67-year-old female, I try to eat responsibly and really feel my condition is hereditary since my two sisters have the same problem. Whatever the cause, my doctor put me on Vytorin to help lower my levels. Is he on the right track, and should I go along with his recommendation, or is there something better out there to get my levels under control? Answer: It depends very much on your own body immune system.  Some cholesterol

[edit] Vytorin Promotion Investigated by States, Justice

8 November 2008, by unknown The Justice Department is investigating whether the promotion of Vytorin led to false claims being submitted to federal healthcare programs, according to an SEC filing.

[edit] Natural cures for high cholesterol

8 November 2008, by Yesterday we talked about the dangers of Vytorin. I have learned since then that the drug Baycol was removed from the market after numerous deaths were attributed to its use.Since all pharmaceuticals carry risk, and since cholesterol drugs seem to carry side effects that lead to death, it seems like it might be a good idea to see what you can do without drugs. According to the Mayo Clinic site, the first thing to do is reduce the amount of saturated and trans fats in your diet. Unfortunately, th

[edit] Cholesterol Drug Vytorin ingredients possibly lethal

7 November 2008, by Isn't that nice? The FDA is beginning an investigation into ezetimibe and simvastatin, the two compounds found in Vytorin which are designed to lower cholesterol levels. A 5-year trial was conducted to see if the combined ingredients could "reduce cardiovascular events in patients with a diagnosis of aortic stenosis." The trial found that no, there were no benefits. However, a larger percentage of those treated with Vytorin (as opposed to the placebo group) were diagnosed with and died from vari

[edit] Vytorin Class Action Lawsuits Mount as Justice Deptartment ... - AboutLawsuits.com

5 November 2008, by

[edit] Vytorin Class Action Lawsuits Mount as Justice Deptartment Investigates

5 November 2008, by Merck & Co. and Schering-Plough Corp. currently face around 140 Vytorin class action lawsuits involving their once-popular cholesterol drug, which has been shown to provide no medical benefits over cheaper generic alternatives. In addition, this week the drug makers disclosed that the U.S. Department of Justice is now investigating their marketing of the medication. Vytorin is a combination of ezetimibe (Zetia) and simvastatin (Zocor). The anti-cholesterol drug was approved by the FDA in 2004

[edit] AstraZeneca's Crestor in spotlight at heart meeting - Reuters

5 November 2008, by

[edit] Simcor, Vytorin and Zocor Associated with Muscle Injury

5 November 2008, by Simcor, Vytorin and Zocor Associated with Muscle Injury Our Simcor, Vytorin and Zocor injury lawyers are investigating claims of severe muscle injury with use of the cholesterol drugs. The injury is called rhabdomyolysis, which can lead to kidney failure or death, when simvastatin containing drugs like Simcor, Vytorin and Zocor are used with amiodarone, a medication used to treat irregular heart beat.  SIGNS & SYMPTOMS RHABDOMYOLYSIS Rhabdomyolysis is [...] Popularity: 9% [?] November

[edit] DOJ, State Attorneys General Investigate Drugmakers’ Marketing (Law.com)

5 November 2008, by As lawsuits pile up against Merck and its partner Schering-Plough over their marketing of Vytorin, the Justice Department has begun investigating whether the drugmakers' promotion of the cholesterol drug resulted in false claims to federal health care programs, Merck noted in a filing to the Securities and Exchange Commission on Monday. A group of 35 state attorneys general are jointly ...

[edit] Merck: More lawsuits, Justice probe over Vytorin (AP)

5 November 2008, by Lawsuits against Merck & Co. and partner Schering-Plough Corp. related to their marketing of cholesterol drug Vytorin are piling up, and the U.S. Department of Justice has begun investigating the drugmakers' conduct, according to a regulatory filing.

[edit] U.S. Probes Marketing of Vytorin

5 November 2008, by riny

[edit] Merck: More lawsuits, Justice probe over Vytorin

4 November 2008, by TRENTON, N.J. - Lawsuits against Merck & Co. and partner Schering-Plough Corp. related to their marketing of cholesterol drug Vytorin are piling up, and the U.S. Department of Justice has begun investigating the drugmakers' conduct, according to a regulatory filing.

[edit] Justice Department & 35 States Probe Vytorin

4 November 2008, by Nothing like being the center of attention. That’s where Merck and Schering-Plough find themselves now that the US Department of Justice and 35 state attorneys general are investigating the marketing of the controversial cholesterol pill. The Justice Department’s civil division sent Merck a letter dated September 10 to say it is investigating whether the drugmakers improperly promoted Vytorin and, as a result, prompted false claims to be submitted to federal health care programs, according to

[edit] Simcor, Vytorin and Zocor Associated with Muscle Injury ...

4 November 2008, by PharmaWatchDog statins, recall, lawyer, simvastatin, attorney, simcor lawyer, vytorin lawyer, zocor lawyer, muscle injury, muscle pain, muscle weakness, muscle stiffness, aching, muscle tenderness.

[edit] Thirty-Five States, Justice Investigating Vytorin Marketing

4 November 2008, by unknown Merck and Schering-Plough have received five civil investigative demands from 35 state attorneys general investigating whether the companies violated state consumer protection laws when marketing their cholesterol drug Vytorin, ...

[edit] shearlings got plowed: Schering Pays Largest Pharma Pricing Fraud …

31 October 2008, by .Missouri Attorney General Jay Nixon reached a $31 million settlement with a pharmaceutical company in a Medicaid fraud case on Friday. New … Excerpt from: shearlings got plowed: Schering Pays Largest Pharma Pricing Fraud …

[edit] shearlings got plowed: Jury in State of Missouri Drug-Pricing …

30 October 2008, by FYI, the linked CafePharma poster puts the verdict for fraud at $7 million — but the penalty phase is still being deliberated — and might thus be a much larger multiple of this $7 million number. We’ll see. … Read the rest here: shearlings got plowed: Jury in State of Missouri Drug-Pricing …

[edit] Upcoming Crestor Study May Be A ‘Game Changer’

30 October 2008, by A forthcoming AstraZeneca study could dramatically increase the market for cholesterol-lowering drugs, otherwise known as statins, which are already pharma’s biggest success story, Forbes writes. Known as Jupiter, the study tested the theory that Crestor combats lower artery inflammation, which can cause cholesterol plaque to burst into heart-attack-causing clots. Some 18,000 people were tested with low levels of LDL, but high levels of C-reactive protein (CRP), which could indicate that the a

[edit] The Handy-Dandy Vytorin Planner Helps You…

29 October 2008, by Let’s see. You can track the monthly drop in prescriptions for the controversial cholesterol pill. You can mark down when additional responses must be given to congressional committees that are conducting investigations (here and here) into the handling of clinical trial data. And you can keep day-to-day tabs on Schering-Plough stock price to see how ceo Fred Hassan is making out with his $2 million investment. And docs can count the days until the drugmaker decides to revive its infamous wine-

[edit] The Handy-Dandy Vytorin Planner Helps You… // Pharmalot

25 October 2008, by Ed Silverman vytorin-calendar Let’s see. You can track the monthly drop in prescriptions for the controversial cholesterol pill. You can mark down when additional responses must be given to congressional committees that are conducting investigations ...

[edit] Vytorin is a alliance product of simvastatin and ezetimibe in use to decrease the manufacture of cholesterol by the liver and inhibit the absorption. Alerts drugs.

24 October 2008, by [Posted 08/21/2008] FDA cultivated healthcare professionals that the Agency is investigating a piece from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) provisional of a plausible guild between the use of Vytorin and a potentially increased prevalence of Cancer. Vytorin is a confederation by-Product of simvastatin and ezetimibe used to dwindle the production of Cholesterol by the liver and bridle the absorption of Cholesterol in the intestine to bust LDL-Cholesterol levels and reduce

[edit] Merck to Axe 7,200 Positions

22 October 2008, by Not much in the way of good news at Merck this morning. The pharma giant announced that it is revising its financial guidelines through 2010, and eliminating 7,200 positions by 2011. The move is expected to save the company $3.8 billion to $4.2 billion through 2013. The layoffs will be staggered throughout different parts of the company, with 40 percent of the reductions being US employees. About 25 percent of the cuts will be senior and middle management Merck President and CEO Richard T. Cl

[edit] Pfizer, Schering-Plough & Roche Earnings Round-Up

21 October 2008, by If numbers tell the story… Pfizer reported that profits tripled thanks to higher sales of the Lyrica pain pill Lyrica and lower costs from 11,000 jobs that were cut last year. Net income rose to $2.28 billion, or 34 cents a share, from $761 million, or 11 cents, a year earlier, when Pfizer took a $2.8 billion charge for the Exubera inhaled insulin device. Revenue was roughly flat at $12 billion. The drugmaker raised the lower end of its forecast for 2008 sales by $1 billion to between $48 billi

[edit] Schering beats forecast, as Vytorin falls

21 October 2008, by NEW YORK (Reuters) - Schering-Plow Corp’s third-quarter earnings fell sharply, hurt by special charges and falling demand for its two cholesterol fighters, but results beat expectations. Klik her for læse hele nyheden

[edit] Vytorin (Ezetimibe and Simvastatin) Drug Information: Uses, Side ...

16 October 2008, by unknown Learn about the prescription medication Vytorin (Ezetimibe and Simvastatin), drug uses, dosage, side effects, drug interactions, warnings, and patient labeling.

[edit] The first-ever, objective side effects comparison of 5 statins: Lipitor, Zocor, Vytorin, Crestor, Pravachol

11 October 2008, by ehealthme A side effects comparison of 5 statins. The tool that did the comparison and other health tools are available on the same site.

[edit] More Trouble for Ezetimibe

5 October 2008, by tseefl